SLC2A1 and thymoma: For example, an analysis of tissue microarrays found that CA9 serves as a diagnostic marker that distinguishes TCs from type B3 thymomas, though the diagnostic specificity and sensitivity of CA9 was not higher compared with those of glucose transporter 1 (GLUT-1) or KIT [15].